These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16288717)

  • 1. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice.
    Chyu KY; Zhao X; Reyes OS; Babbidge SM; Dimayuga PC; Yano J; Cercek B; Fredrikson GN; Nilsson J; Shah PK
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1982-9. PubMed ID: 16288717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
    Fredrikson GN; Björkbacka H; Söderberg I; Ljungcrantz I; Nilsson J
    J Intern Med; 2008 Dec; 264(6):563-70. PubMed ID: 18783480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.
    Fredrikson GN; Andersson L; Söderberg I; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Autoimmunity; 2005 Mar; 38(2):171-9. PubMed ID: 16040338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
    Fredrikson GN; Söderberg I; Lindholm M; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):879-84. PubMed ID: 12649092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.
    Caligiuri G; Nicoletti A; Poirier B; Hansson GK
    J Clin Invest; 2002 Mar; 109(6):745-53. PubMed ID: 11901183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
    Schiopu A; Bengtsson J; Söderberg I; Janciauskiene S; Lindgren S; Ares MP; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
    Circulation; 2004 Oct; 110(14):2047-52. PubMed ID: 15451805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice.
    Chyu KY; Reyes OS; Zhao X; Yano J; Dimayuga P; Nilsson J; Cercek B; Shah PK
    Atherosclerosis; 2004 Sep; 176(1):27-35. PubMed ID: 15306171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide.
    Chyu KY; Zhao X; Dimayuga PC; Zhou J; Li X; Yano J; Lio WM; Chan LF; Kirzner J; Trinidad P; Cercek B; Shah PK
    PLoS One; 2012; 7(2):e30780. PubMed ID: 22347402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
    Fredrikson GN; Lindholm MW; Ljungcrantz I; Söderberg I; Shah PK; Nilsson J
    Autoimmunity; 2007 Mar; 40(2):122-30. PubMed ID: 17453711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
    Cesena FH; Dimayuga PC; Yano J; Zhao X; Kirzner J; Zhou J; Chan LF; Lio WM; Cercek B; Shah PK; Chyu KY
    Atherosclerosis; 2012 Jan; 220(1):59-65. PubMed ID: 22062590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular immunization with a DNA vaccine encoding a 26-amino acid CETP epitope displayed by HBc protein and containing CpG DNA inhibits atherosclerosis in a rabbit model of atherosclerosis.
    Mao D; Kai G; Gaofu Q; Zheng Z; Li Z; Jie W; Jingjing L; Rongyue C
    Vaccine; 2006 Jun; 24(23):4942-50. PubMed ID: 16697088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
    Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
    Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.
    Nilsson J; Björkbacka H; Fredrikson GN
    Curr Opin Lipidol; 2012 Oct; 23(5):422-8. PubMed ID: 22814703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation of atherosclerosis with a vaccine.
    Shah PK; Chyu KY; Fredrikson GN; Nilsson J
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):639-46. PubMed ID: 16306920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
    Okabe TA; Shimada K; Hattori M; Murayama T; Yokode M; Kita T; Kishimoto C
    Cardiovasc Res; 2007 Jun; 74(3):537-45. PubMed ID: 17374527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.
    Yamashita T; Freigang S; Eberle C; Pattison J; Gupta S; Napoli C; Palinski W
    Circ Res; 2006 Sep; 99(7):e51-64. PubMed ID: 16946133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atheroprotective effects of bilberry extracts in apo E-deficient mice.
    Mauray A; Milenkovic D; Besson C; Caccia N; Morand C; Michel F; Mazur A; Scalbert A; Felgines C
    J Agric Food Chem; 2009 Dec; 57(23):11106-11. PubMed ID: 19891504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.